Back to Entrada Therapeutics, Inc.

Entrada Therapeutics, Inc.

All insiders

6 insiders

InsiderRole% of sharesShares heldLast trade
Doshi DipalCEO · Director1.35%526,014Mar 3, 2026
Sethuraman NatarajanPresident, Research & Develop.0.62%242,224Mar 3, 2026
Dowden Nathan JPresident & COO0.51%198,588Mar 10, 2026
WENTWORTH KORY JAMESChief Financial Officer0.31%121,510Mar 10, 2026
KIM PETER SDirectorJun 10, 2026
Thistle MaryDirectorJun 10, 2026
← PrevPage 1 of 1Next →